Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

GlaxoSmithKline Pharmaceuticals Ltd

NSE: GLAXO · BSE: 500660 · Pharmaceuticals & Biotechnology · 34 announcements

Share price
₹2,634.00
Market cap
₹44,622 Cr
Revenue (annual)
₹3,822 Cr
Net profit (annual)
₹1,036 Cr
P/E (TTM)
41.8×Sector 47.3×
Promoter holding
75.00%+0.00% QoQ
FII holding
4.79%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

12:47 IST BSE
Annual General Meeting

GlaxoSmithKline Pharmaceuticals Annual General Meeting

GSK Pharma's postal ballot approved Ms. Natland as NED and Mr. Akshikar's MD re-appointment. Both resolutions cleared with over 99% shareholder support.

15:31 IST BSE
Annual General Meeting

GlaxoSmithKline Pharmaceuticals Annual General Meeting

GlaxoSmithKline Pharmaceuticals issued a corrigendum for its August 3, 2026, postal ballot notice, correcting a typographical error in a reported salary figure.

13:02 IST BSE
Annual General Meeting

GlaxoSmithKline Pharmaceuticals Annual General Meeting

GlaxoSmithKline Pharmaceuticals has issued a Postal Ballot notice for shareholder approval. The resolutions involve appointing Karine J F Natland and re-appointing Bhushan Akshikar as Managing Director.

19:49 IST BSE
Annual General Meeting

GlaxoSmithKline Pharmaceuticals Annual General Meeting

GlaxoSmithKline Pharmaceuticals has issued notice for its 101st AGM scheduled for June 30, 2026. Shareholders will consider a Rs. 57 per share dividend declaration.

23:24 IST BSE
Annual General Meeting

GlaxoSmithKline Pharmaceuticals Annual General Meeting

GlaxoSmithKline Pharmaceuticals Ltd announced that shareholders approved the appointment of Mr. Ronojit Biswas as Director and Whole-time Director & CFO via postal ballot. The ordinary resolutions were passed with over 99.6% majority. This confirms leadership stability for the company's financial and administrative operations.